Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions

Share


Latest Cancer News


Important Clues in the Development of Aggressive Thyroid Cancer (April 16, 2015)

New insight into how anaplastic thyroid cancer (ATC) grows and spreads may provide important direction in the development of treatment. These findings were published in the Journal of Clinical Endocrinology... Continue Reading

Radiofrequency Ablation in Barrett’s Esophagus May Prevent Esophageal Cancer (April 15, 2015)

Treatment of Barrett’s esophagus with radiofrequency ablation appears to keep the condition from progressing to esophageal cancer. These findings were published in the Journal of the American Medical... Continue Reading

Unituxin® Approved for Treatment of Children with High-Risk Neuroblastoma (April 14, 2015)

The U.S. Food and Drug Administration (FDA) has announced the first-ever drug approval for the treatment of children with high-risk neuroblastoma. In clinical trials Unituxin® (dinutuximab) has improved... Continue Reading

Have a Question about Polycythemia Vera? Ask the Expert! (April 13, 2015)

CancerConnect Presents: Ask the Expert with Dr. Mesa CancerConnect announces the opportunity to engage with a polycythemia vera (PV) expert, Ruben A. Mesa, MD. On April 29, 2015, Dr. Mesa will answer your... Continue Reading

Researchers Develop New Potential Drug for Rare Leukemia; Separate Study Suggests Possible Role in Prostate Cancer Treatment (April 13, 2015)

Researchers Develop New Potential Drug for Rare Leukemia; Separate Study Suggests Possible Role in Prostate Cancer Treatment ANN ARBOR, Mich. — Researchers at the University of Michigan have developed... Continue Reading

Jakafi® Provides Important Symptom Relief in Patients with Polycythemia Vera (April 9, 2015)

A Phase III trial finds that Jakafi® (ruxolitinib) more effectively controls symptoms than standard therapy for patients with polycythemia vera (PV). These findings were published in the New England Journal... Continue Reading

April Is Irritable Bowel Syndrome Awareness Month (April 8, 2015)

The month of April brings irritable bowel syndrome (IBS) into focus. This is a great time to increase your understanding of this gastrointestinal condition, learn more about managing it, and connect with... Continue Reading

National Head and Neck Cancer Awareness Month on CancerConnect (April 8, 2015)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of head and neck cancer educational programs for national head and neck cancer awareness month. As the month of... Continue Reading

NW Bio Reports Promising Survival Data In 51 GBM Patients Treated With DCVax®-L (April 8, 2015)

BETHESDA, MD, March 27, 2015 – Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that... Continue Reading

National Testicular Cancer Awareness Month on CancerConnect (April 7, 2015)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of testicular cancer educational programs for national testicular cancer awareness month. As the month of April... Continue Reading

Tasigna® Remains Superior to Gleevec® for Treatment of Newly Diagnosed Patients With Chronic Myeloid Leukemia (April 7, 2015)

Tasigna® (nilotinib) remains superior to Gleevec® (imatinib) for the treatment of patients with Philadelphia chromosome-positive chronic myeloid leukemia (PH+CML), according to the results of the six-year... Continue Reading

National Esophageal Cancer Awareness Month on CancerConnect (April 6, 2015)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of esophageal cancer educational programs for national esophageal cancer awareness month. As the month of April... Continue Reading

Most Women with Early-Stage Breast Cancer Avoid Extensive Lymph Node Removal, Showing Increasing Adherence to Scientific Evidence that a Radical Operation Is No Longer Necessary (April 6, 2015)

NEWS FROM THE AMERICAN COLLEGE OF SURGEONS  CHICAGO (March 26, 2015): A new study of women with early-stage breast cancer finds that surgeons no longer universally remove most of the lymph nodes in the... Continue Reading

Medical and dental centers throughout U.S. will take part in 18th annual OHANCAW®, April 12-18 (April 2, 2015)

NEW YORK, NY, march 24, 2015 – Donnie Walsh, former President of the Indiana Pacers and New York Knicks and an oral cancer survivor, is urging Americans to get screened for cancer during the 18th annual... Continue Reading

International Marrow Donor Registries Reach 25 Million Potential Donors, Give Hope to Searching Blood Cancer Patients Around the World (April 1, 2015)

CancerConnect News: This week, Bone Marrow Donors Worldwide (BMDW) and the World Marrow Donor Association (WMDA) announced that a record 25 million people worldwide are currently listed as potential volunteer... Continue Reading

Chemotherapy after Surgery Appears to Improve Survival in Advanced Bladder Cancer (March 31, 2015)

Patients with advanced bladder cancer who receive chemotherapy after surgery to remove the bladder have better overall survival than patients who undergo surgery alone. These findings were presented at... Continue Reading

Health Quest Brings Cancer Patients Support with CancerConnect (March 30, 2015)

LaGrange, N.Y. – March 30, 2015 Post questions, comment on discussions and find support about living with cancer by signing up for Health Quest’s newly launched CancerConnect. This online community... Continue Reading

Votrient® plus Taxol® Promising in Relapsed and Refractory Bladder Cancer (March 30, 2015)

The treatment combination of Votrient® (pazopanib) plus Taxol® (paclitaxel) appears active against bladder cancer that has not responded to or come back after previous therapy. These findings were presented... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions


Cancer Types



Headline News by Cancer Type


Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS